Schlesinger launches clinical research brand
Schlesinger Clinical Research will bring together all of the company’s data collection work needed for clinical research.
The new branch of the company will be based across 30 sites and will oversee the recruitment and consistent application of clinical study research protocols, and will initially focus on non-prescription drugs.
Rob Ramirez, executive vice-president Schlesinger Group, said Schlesinger Clinical Research would bring “site selection, subject enrolment and study execution expertise under one partner”.
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments